BioSpace News Archive

FDA

FDA Greenlights First Bi-Monthly Injectable for Schizophrenia, Bipolar 1 Disorder

Otsuka and Lundbeck won approval Friday for Abilify Asimtufii, a long-acting injectable that provides two months of symptom relief in patients with schizophrenia or bipolar I disorder.

May 1, 2023
·
2 min read
·
Tristan Manalac
FDA

FDA Panel Supports Narrow Lynparza Label for Prostate Cancer

The Oncologic Drugs Advisory Committee voted 11–1 supporting Merck’s and AstraZeneca’s PARP inhibitor for metastatic castration-resistant prostate cancer patients with BRCA mutations.

May 1, 2023
·
3 min read
·
Tristan Manalac
Deals

Astellas to Buy Iveric Bio for $5.9B in Age-Related Blindness Play

Japanese biopharma scoops up Iveric’s investigational drug for age-related blindness disease. The drug, which trails Apellis’ Syfovre, is awaiting FDA approval with a decision expected by August.

May 1, 2023
·
2 min read
·
Kate Goodwin
Biotech Bay

Mainz Biomed to Participate in Digestive Disease Week 2023

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced its participation in the annual Digestive Disease Week conference being held this year May 6-9 in Chicago, IL.

May 1, 2023
·
6 min read
Policy

RadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 Software

RadNet, Inc., announced that it has received FDA clearance for the third-generation release of its Quantib Prostate™ 3.0 MRI artificial intelligence software, further enhancing the offering with new and updated tools.

May 1, 2023
·
4 min read
Business

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors

Ovid Therapeutics Inc. and Graviton Bioscience Corporation announced a collaboration agreement to innovate novel medicines that they believe will significantly change the treatment paradigm for serious, rare neurological diseases.

May 1, 2023
·
8 min read
BioMidwest

Exact Sciences to participate in May 2023 investor conference

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that company management will participate in the following conference and invited investors to participate by webcast.

May 1, 2023
·
1 min read
Biotech Bay

IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations event.

May 1, 2023
·
2 min read
BioForest

SystImmune, Inc. to Present New Data from Oncology Programs at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2023

Systimmune, Inc. announced that it will present clinical data from its lead programs at the ASCO Annual Meeting 2023 in Chicago in June.

May 1, 2023
·
7 min read
BioMidwest

Rockwell Medical Announces Global Expansion into the United Arab Emirates

Rockwell Medical, Inc. announced that the Company expanded its geographic footprint by entering a long-term supply agreement with Global Medical Supply Chain LLC to begin selling Rockwell’s hemodialysis concentrates products into the United Arab Emirates.

May 1, 2023
·
4 min read